Margareta Elisabeth Björk
Director/Board Member at PHARVARIS N.V.
Net worth: - $ as of 2024-03-30
Profile
Dr. Margareta Elisabeth Björk is an Independent Non-Executive Director at Calliditas Therapeutics AB, an Independent Non-Executive Director at Pharvaris NV, an Independent Director at Rocket Pharmaceuticals, Inc., a Senior VP & Head-Late-stage Development at AstraZeneca PLC and an Associate Professor at University of Uppsala.
She is on the Board of Directors at Vicore Pharma Holding AB, Calliditas Therapeutics AB, Pharvaris NV, Rocket Pharmaceuticals, Inc., Björks Matematik o Mera AB, Chalmers University of Technology and Rfidcompare Europe AB.
Dr. Björk was previously employed as a Head-Diabetes & Endocrinology Unit by Uppsala University Hospital.
She also served on the board at Albireo Ltd.
She received her doctorate degree from Karolinska Institutet and a doctorate degree from the University of Uppsala.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-21 | 0 ( -.--% ) | - $ | 2024-03-30 | |
PHARVARIS N.V.
-.--% | 2023-03-09 | 0 ( -.--% ) | - $ | 2024-03-30 |
Margareta Elisabeth Björk active positions
| Companies | Position | Start |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2012-05-31 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 2020-04-19 |
| PHARVARIS N.V. | Director/Board Member | 2021-11-30 |
| CALLIDITAS THERAPEUTICS AB | Director/Board Member | 2021-12-31 |
| VICORE PHARMA HOLDING AB | Director/Board Member | 2022-12-31 |
| University of Uppsala | Corporate Officer/Principal | - |
| Chalmers University of Technology | Director/Board Member | - |
| Björks Matematik o Mera AB | Director/Board Member | - |
| Rfidcompare Europe AB | Director/Board Member | - |
Former positions of Margareta Elisabeth Björk
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Margareta Elisabeth Björk
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| PHARVARIS N.V. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
| Björks Matematik o Mera AB | |
| Rfidcompare Europe AB |
- Stock Market
- Insiders
- Margareta Elisabeth Björk
